PulseAI Raises in Seed Funding

Seed funding will support clinical validation, a US regulatory submission and integration with medical-device makers.

Round size
Undisclosed
Stage
Seed
Headquarters
United Kingdom
Announced
Jan 12, 2026

Software behind the ECG reading

The Belfast company builds an analysis layer for cardiac diagnostics. Its algorithms process ECG signals and provide clinical decision support, with device manufacturers and hospital networks among its intended partners.

Preparing for wider clinical use

Innovation Ulster Limited led the investment, joined by The Mortara Group and The Francis Crick Institute. The company will expand clinical validation, prepare for FDA 510(k) clearance and develop enterprise and equipment integrations. ECG technology veteran Justin Mortara will become board chair.

Where the funding goes

  • Clinical validation and FDA 510(k) regulatory work
  • Enterprise and medical-device integrations
  • Partnerships with device manufacturers and hospitals

Sources

  1. PulseAI: funding announcement
  2. PulseAI: ECG analysis and device integration
  3. Pulse 2.0: seed financing report
03 / Related rounds

Related funding rounds

01
Seed · AI

humans&

humans& is developing AI models for communication and collaboration between people, with research in memory, user understanding and multi-agent reinforcement learning.

Led by SV Angel, Georges Harik
$480M
02
Seed · Neurotechnology

Merge Labs

Merge Labs researches brain-computer interfaces that combine molecular engineering, ultrasound and AI to communicate with neural activity without implants inside brain tissue.

$252M
03
Series C+ · Healthtech

OpenEvidence

OpenEvidence is a medical search engine that answers clinicians’ questions with citations to peer-reviewed journals, clinical literature and professional guidelines.

Led by Thrive Capital, DST Global
$250M